The NIHR's Response to COVID-19
The NIHR has established a single, national prioritisation process for COVID-19 research to prevent duplication of effort and ensure that the resources and capacity of the healthcare system are not exceeded.
Find out moreIndustry
We advise on the suitability of new technologies and the evidence required to support their commercial uptake.
Clinicians
We broker collaborations between industry and clinical practice to test new technologies in community settings.
Patients
Our public contributors help steer and govern our work to ensure it is relevant to patients and carers.
Research and resources
>Theme 1: Acute paediatrics
> Theme 2: Precision antimicrobial prescribing
> Theme 3: Long-term conditions
> Theme 4: Acute adult ambulatory care
Latest news
Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system.
30 November 2021
Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.
BLOG: Natriuretic peptide testing and heart failure survival
28 June 2021
NIHR Academic Clinical Lecturer and GP Dr Clare Taylor gives a breakdown of the findings and their importance of a recent publication on heart failure and natriuretic peptide testing by herself and colleagues.
Register for our newsletter
Get details on the latest news, opportunities and upcoming events with our quarterly email bulletin. You may also register for our public newsletter, produced in partnership with the University of Oxford and the NIHR CLAHRC Oxford.
Join our LinkedIn Group
Join the In Vitro Diagnostics in Primary Care LinkedIn Group and share your own news and opportunities with clinicians, researchers, industry representatives and healthcare delivery professionals.